irsogladine has been researched along with Reperfusion Injury in 2 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We tested the hypothesis that maintenance of GJIC protects rat gastric mucosa against ischemia-reperfusion (I/R) stress by using irsogladine, an activator of GJIC, and octanol, an inhibitor of GJIC." | 3.70 | Role of gap junctions in inhibiting ischemia-reperfusion injury of rat gastric mucosa. ( Itoh, M; Iwata, F; Joh, T; Ueda, F; Yokoyama, Y, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyoi, T | 1 |
| Kitazawa, S | 1 |
| Tajima, K | 1 |
| Zhang, X | 1 |
| Ukai, Y | 1 |
| Iwata, F | 1 |
| Joh, T | 1 |
| Ueda, F | 1 |
| Yokoyama, Y | 1 |
| Itoh, M | 1 |
2 other studies available for irsogladine and Reperfusion Injury
| Article | Year |
|---|---|
Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-U | 2004 |
Role of gap junctions in inhibiting ischemia-reperfusion injury of rat gastric mucosa.
Topics: Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; Cell Communication; Chromium Radioisotopes; Conn | 1998 |